ADC Therapeutics SA
ADCT- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001771910
No open-market purchases or sales by ADC Therapeutics SA insiders were filed in the last 90 days; 113 institutions reported holding it in 13F filings for Q2 2026, worth $86.3M in total; no superinvestor holds it.
Q1 2025 vs. Q4 2024
How the institutions holding ADC Therapeutics SA changed between Q4 2024 and Q1 2025.
All holders in Q1 2025All holders in Q4 2024
| Measure | Q4 2024 | Of which not filed for Q1 2025 | Q1 2025 | Change |
|---|---|---|---|---|
| Holders | 83 | 1 | 82 | 0 |
| Shares | 56.5M | 152.0K | 54.8M | −1.51M (−2.7%) |
| Value | $112.4M | $302.6K | $77.3M | −$34.8M (−31.0%) |
1 institution that held it in Q4 2024 haven't filed for Q1 2025 yet. Not filing isn't selling, so the changes leave them out.
New holders (13)
Institutions that held ADC Therapeutics SA at the end of Q1 2025 but not at the end of Q4 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Nuveen, LLC | 152,047 | $214.4K | 0.00% |
| Panagora Asset Management Inc | 54,186 | $76.4K | 0.00% |
| Ieq Capital, LLC | 22,925 | $32.3K | 0.00% |
| Atria Wealth Solutions, Inc. | 20,000 | $28.2K | 0.00% |
| CIBC World Markets Corp | 18,044 | $25.4K | 0.00% |
| Cerity Partners LLC | 17,912 | $25.3K | 0.00% |
| Wealth Enhancement Advisory Services, LLC | 14,990 | $21.1K | 0.00% |
| Diversified Trust Co | 14,115 | $19.9K | 0.00% |
| Coldstream Capital Management Inc | 455 | $642 | 0.00% |
| True Wealth Design, LLC | 93 | $132 | 0.00% |
| GoalVest Advisory LLC | 50 | $71 | 0.00% |
| South State Corp. | 46 | $65 | 0.00% |
| TSFG, LLC | 100 | $0 | 0.00% |
Sold out (13)
Institutions that held ADC Therapeutics SA at the end of Q4 2024 and filed for Q1 2025 without it.
| Institution | Shares, Q4 2024 | Value, Q4 2024 |
|---|---|---|
| Wellington Management Group LLP | 253,342 | $504.1K |
| Two Sigma Advisers, LP | 65,267 | $129.9K |
| Prudential Financial Inc | 17,430 | $34.7K |
| Readystate Asset Management LP | 15,620 | $31.1K |
| Two Sigma Securities, LLC | 15,048 | $29.9K |
| HRT Financial LP | 15,073 | $29.0K |
| Kazazian Asset Management, LLC | 13,300 | $26.5K |
| Kestra Advisory Services, LLC | 10,002 | $19.9K |
| State of Wyoming | 8,267 | $16.5K |
| Simplex Trading, LLC | 5,291 | $10.0K |
| Eagle Bay Advisors LLC | 670 | $1.33K |
| Creative Planning | 475 | $945 |
| The PNC Financial Services Group, Inc. | 250 | $498 |
Not filed for Q1 2025 yet (1)
Institutions that held ADC Therapeutics SA at the end of Q4 2024 and haven't filed a 13F for Q1 2025. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2024 | Value, Q4 2024 |
|---|---|---|
| Nuveen Asset Management, LLC | 152,047 | $302.6K |